Web Results

www.ediscoverylaw.com/wp-content/uploads/2016/01/Gilead-v-Merck-co.pdf

Jan 13, 2016 ... v. MERCK & CO, INC., et al.,. Defendants. Case No. 5:13-cv-04057-BLF ... Merck asserts that Gilead infringes two of its patents to a certain kind ...

www.law360.com/cases/5362954575127729f8000001

Parties, docket activity and news coverage of federal case Gilead Sciences, Inc. v . Merck & Co, Inc. et al, case number 5:13-cv-04057, from California Northern ...

www.law360.com/cases/5362954575127729f8000001/articles

Coverage of federal case Gilead Sciences, Inc. v. Merck & Co, Inc. et al, case number 5:13-cv-04057, from California Northern Court.

bernllp.com/lawsuits-filed-against-merck-alleging-shingles-zostavax-vaccine-defective

May 23, 2018 ... *Daniel Caudillo, et al. v. Merck & Co., Inc., et al. (Super. Ct. Alameda County, No. RG17857096.) Barbara Gregory, et al. v. Merck & Co., Inc., et ...

circ.ahajournals.org/content/circulationaha/110/8/921.full.pdf

Merck Research Laboratories, Merck & Co, Inc, Whitehouse Station, .... Treatment (losartan vs placebo). 0.66 ..... Keane WF, Brenner BM, de Zeeuw D, et al.

www.kidney-international.org/article/S0085-2538(15)49188-4/fulltext

Barry M. Brenner ... Merck & Co., Inc., West Point, Pennsylvania, USA .... Estacio et al (1998), Bakris et al (1996), ACE inhibitor vs. calcium channel antagonist].

www.ncbi.nlm.nih.gov/pmc/articles/PMC26412

All of these reagents have been shown to recognize l-selectin (14–17, 21–26). ... kinase activity and co-immunoprecipitation of Sos, Grb2, Shc, and l-selectin, cells ... layer chromatography polyethyleneimine-cellulose plate (Merck) with 0.75 M ..... Gulbins E, Coggeshall K M, Brenner B, Schlottmann K, Linderkamp O, Lang F.

www.wikijournalclub.org/wiki/RENAAL

Dec 3, 2017 ... Brenner BM, et al. "Effects of losartan on renal and ... Outcomes. Comparisons are losartan vs. placebo. ... Funding. Merck and Company ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC5397237

Apr 1, 2017 ... Clark NM, Brenner J, Johnson P, et al. Reducing disparities in diabetes: the alliance model for health care improvements. Diabetes Spectr 2011 ...